论文部分内容阅读
了解国内肝癌高发区ＨＢＶ、ＨＣＶ的流行情况及其与肝癌发病的关系。方法：在肝癌高发的江苏 省启东地区，对不同人群进行血清ＨＢｓＡｇ（固相放免法）、抗－ＨＣＶ（酶免法）、ＡＦＰ（固相放免法）测定，结果进行统计 学处理。结果：肝癌、肝炎、献血员三组人群中ＨＢｓＡｇ 及抗－ＨＣＶ阳性率分别为８６．０２％与７．５３％，５９．８１％与 ０．９３％，４．０４％与４．０４％。血清ＨＢｓＡｇ及ＡＦＰ含量与抗－ＨＣＶ间无明显关系。结论：国内肝癌高发区人群主要感 染ＨＢＶ并与肝癌发生有关，ＨＣＶ感染并不重要。
To understand the prevalence of HBV and HCV in high-risk areas of domestic liver cancer and its relationship with the incidence of liver cancer. Methods: Serum HBsAg (solid phase radioimmunoassay), anti-HCV (enzyme immunoassay), and AFP (solid phase radioimmunoassay) assays were performed on different populations in the Qidong region of Jiangsu Province with high incidence of hepatocellular carcinoma. Results were analyzed statistically. Results: The positive rates of HBsAg and anti-HCV in the three groups of liver cancer, hepatitis, and blood donors were 86.02% and 7.53%, 59.81% and 0.93%, 4.04% and 4.04%, respectively. . There was no significant relationship between serum HBsAg and AFP levels and anti-HCV. Conclusion: In the high-incidence areas in China, the population is mainly infected with HBV and is associated with liver cancer. HCV infection is not important.